Showing 1 - 20 results of 21 for search 'Hans Blokzijl', query time: 0.06s
Refine Results
-
1
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation [v1; ref status: indexed, http://f1000r.es/3ah] by Freeha Arshad, Jelle Adelmeijer, Hans Blokzijl, Aad van den Berg, Robert Porte, Ton Lisman
Published 2014-05-01
Article -
2
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation [v2; ref status: indexed, http://f1000r.es/40n] by Freeha Arshad, Jelle Adelmeijer, Hans Blokzijl, Aad van den Berg, Robert Porte, Ton Lisman
Published 2014-07-01
Article -
3
-
4
Clinical and Therapeutic Implications of BCAAs Metabolism during Chronic Liver Disease in Humans: Crosstalk between Skeletal Muscle and Liver by Maria Camila Trillos-Almanza, Magnolia Martinez-Aguilar, Johanna C. Arroyave-Ospina, Frederike van Vilsteren, Hans Blokzijl, Han Moshage
Published 2024-03-01
Article -
5
-
6
-
7
‘Effects of a home-based bimodal lifestyle intervention in frail patients with end-stage liver disease awaiting orthotopic liver transplantation’: study protocol of a non-randomise... by Hans Blokzijl, Vincent E de Meijer, Rienk Dekker, Joost M Klaase, Coby Annema, Bart C Bongers, Allard G Wijma, Job AM van der Palen, Frans JC Cuperus
Published 2024-01-01
Article -
8
Assessing the Potential of Untargeted SWATH Mass Spectrometry-Based Metabolomics to Differentiate Closely Related Exposures in Observational Studies by Frank Klont, Piotr Sosnowski, Daan Kremer, Tim J. Knobbe, Ron Bonner, Hans Blokzijl, Rinse K. Weersma, Stephan J. L. Bakker, TransplantLines Investigators, Eelko Hak, Daan J. Touw, Gérard Hopfgartner
Published 2022-10-01
Article -
9
Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein by Eline H. van den Berg, Jose L. Flores-Guerrero, Eke G. Gruppen, Erwin Garcia, Margery A. Connelly, Vincent E. de Meijer, Stephan J. L. Bakker, Hans Blokzijl, Robin P. F. Dullaart
Published 2022-02-01
Article -
10
Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population by Arno R. Bourgonje, Eline H. van den Berg, Lyanne M. Kieneker, Tom Nilsen, Clara Hidden, Stephan J. L. Bakker, Hans Blokzijl, Robin P. F. Dullaart, Harry van Goor, Amaal E. Abdulle
Published 2022-12-01
Article -
11
Exhaled Hydrogen as a Marker of Intestinal Fermentation Is Associated with Diarrhea in Kidney Transplant Recipients by Fernanda Guedes Rodrigues, J. Casper Swarte, Rianne M. Douwes, Tim J. Knobbe, Camilo G. Sotomayor, Hans Blokzijl, Rinse K. Weersma, Ita P. Heilberg, Stephan J. L. Bakker, Martin H. de Borst, TransplantLines Investigators
Published 2021-06-01
Article -
12
Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications by Zongmei Wu, Mengmeng Xia, Sandra Serna Salas, Maria Camila Trillos-Almanza, Magnolia Martinez Aguilar, Johanna C. Arroyave-Ospina, Junyu Wang, Marco Arrese, Svenja Sydor, Lars P. Bechmann, Frederike GI van Vilsteren, Hans Blokzijl, Han Moshage
Published 2022-07-01
Article -
13
Branched Chain Amino Acids Are Associated with Physical Performance in Patients with End-Stage Liver Disease by Maria Camila Trillos-Almanza, Hanna Wessel, Magnolia Martínez-Aguilar, Eline H. van den Berg, Rianne M. Douwes, Han Moshage, Margery A. Connelly, Stephan J. L. Bakker, Vincent E. de Meijer, Robin P. F. Dullaart, Hans Blokzijl
Published 2023-05-01
Article -
14
Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation. by Marcel Janse, Bert-Jan F de Rooij, Bart van Hoek, Arie P van den Berg, Robert J Porte, Hans Blokzijl, Minneke J Coenraad, Bouke G Hepkema, Alexander F Schaapherder, Jan Ringers, Rinse K Weersma, Hein W Verspaget
Published 2013-01-01
Article -
15
The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030 by Marleen van Dijk, Sylvia M. Brakenhoff, Cas J. Isfordink, Wei-Han Cheng, Hans Blokzijl, Greet Boland, Anthonius S. M. Dofferhoff, Bart van Hoek, Cees van Nieuwkoop, Milan J. Sonneveld, Marc van der Valk, Joost P. H. Drenth, Robert J. de Knegt
Published 2021-09-01
Article -
16
The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study. by Rianne M Douwes, António W Gomes-Neto, Michele F Eisenga, Elisabet Van Loon, Joëlle C Schutten, Rijk O B Gans, Maarten Naesens, Else van den Berg, Ben Sprangers, Stefan P Berger, Gerjan Navis, Hans Blokzijl, Björn Meijers, Stephan J L Bakker, Dirk Kuypers
Published 2020-06-01
Article -
17
Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study. by Floor A C Berden, Robert J de Knegt, Hans Blokzijl, Sjoerd D Kuiken, Karel J L van Erpecum, Sophie B Willemse, Jan den Hollander, Marit G A van Vonderen, Pieter Friederich, Bart van Hoek, Carin M J van Nieuwkerk, Joost P H Drenth, Wietske Kievit
Published 2016-01-01
Article -
18
Orthotopic Liver Transplantation in Glycogen Storage Disease Type 1a by Matheus V. M. B. Wilke BSc, Ruben H. de Kleine MD, J. K. G. Wietasch MD, PhD, Cynthia C. A. van Amerongen BSc, Hans Blokzijl MD, PhD, Francjan J. van Spronsen MD, PhD, Ida V. D. Schwartz MD, PhD, Terry G. J. Derks MD, PhD
Published 2016-05-01
Article -
19
Health-related quality of life is linked to the gut microbiome in kidney transplant recipients by J. Casper Swarte, Tim J. Knobbe, Johannes R. Björk, Ranko Gacesa, Lianne M. Nieuwenhuis, Shuyan Zhang, Arnau Vich Vila, Daan Kremer, Rianne M. Douwes, Adrian Post, Evelien E. Quint, Robert A. Pol, Bernadien H. Jansen, TransplantLines investigators, Martin H. de Borst, Vincent E. de Meijer, Hans Blokzijl, Stefan P. Berger, Eleonora A. M. Festen, Alexandra Zhernakova, Jingyuan Fu, Hermie J. M. Harmsen, Stephan J. L. Bakker, Rinse K. Weersma
Published 2023-12-01
Article -
20
Prolonged hypothermic machine perfusion enables daytime liver transplantation – an IDEAL stage 2 prospective clinical trialResearch in context by Isabel M.A. Brüggenwirth, Veerle A. Lantinga, Bianca Lascaris, Adam M. Thorne, Mark Meerdink, Ruben H. de Kleine, Hans Blokzijl, Aad P. van den Berg, Koen M.E.M. Reyntjens, Ton Lisman, Robert J. Porte, Vincent E. de Meijer, Vincent E. de Meijer, Isabel M.A. Brüggenwirth, Veerle A. Lantinga, Cyril Moers, Diethard Monbaliu, Sijbrand H. Hofker, Jan Bottema, Hildegaard S. Franke, Marieke T. de Boer, Anne Loes van den Boom, Carlijn I. Buis, Suomi M.G. Fouraschen, Frederik J.H. Hoogwater, Vincent E. de Meijer, Joost M. Klaase, Ruben H.J. de Kleine, Mark Meerdink, Maarten W. Nijkamp, Robert J. Porte, A. Michel Rayar, Aad P. van den Berg, Hans Blokzijl, Frans J.C. Cuperus, Frans van der Heide, Frederike G.I. van Vilsteren, Ilhama F. Abbasova, Meine H. Fernhout, Peter Meyer, Ernesto R.R. Muskiet, Koen M.E.M. Reyntjens, Jaap J. Vos, Miriam Zeillemaker, Isabel M.A. Brüggenwirth, Martijn P.D. Haring, Veerle A. Lantinga, Bianca Lascaris, Carol C. Pamplona, Adam M. Thorne, Vivianne Veenma, Otto B. van Leeuwen, Silke B. Bodewes, Ton Lisman, Jelle Adelmeijer, Janneke Wiersema-Buist, Marius van den Heuvel
Published 2024-02-01
Article